Nanotechnology for Cancer Treatment: An Introduction

Author:

Mazahir Farhan1,Pathak Anchal1,Gupta Ujala1,Yadav Awesh K.1

Affiliation:

1. National Institute of Pharmaceutical Education and Research,Raebareli,India,

Abstract

Cancer is the leading cause of death worldwide. The treatment of cancer remains a challenge for medical professionals. Although various options, like chemotherapy, radiation, and surgery, are available to manage cancer, their use could be limited due to serious adverse effects. Therefore, advancements are highly essential to treat cancer properly. Nanotechnology provides new rays of hope for the effective treatment of cancer. Nanotechnology-based drug delivery carriers (NCs), such as nanoparticles, liposomes, dendrimers, polyplexes, and many more, offer treatment strategies due to their ability to target cancer cells. As these NCs target cancer cells, the exposure of other tissues to the drug is very less. Hence, these NCs exhibit fewer side effects in comparison with standard anti-cancer drugs. Here, we try to summarize a precise introduction of different NCs and their role in cancer therapy. <b></b><br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference126 articles.

1. Shi Y; van der Meel R; Chen X; Lammers T.; The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy 2020,10,7921-7924

2. Golombek SK; May JN; Theek B; Tumor targeting via EPR: Strategies to enhance patient responses 2018,130,17-38

3. Rosenblum D.; Joshi N.; Tao W.; Karp J.M.; Peer D.; Progress and challenges towards targeted delivery of cancer therapeutics Internet2018,Vol. 9,1-12 www.nature.com/naturecommunications

4. FDA https://www.fda.gov/regulatory-information/search-fda-guidance documents/considering-whether-fda-regulated-product-involves-application-nanotechnology

5. Yadav A.K.; Mishra P.; Mishra A.K.; Mishra P.; Jain S.; Agrawal G.P.; Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of DOX. Nanomedicine Nanotechnology. Biol Med [Internet].2007,3(4),246-257 https://pubmed.ncbi.nlm.nih.gov/18068091/

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3